BETA

IPO registrations (S-1, F-1) · Registrants

Chelsea Therapeutics International, Ltd.

SEC CIK
1333763 · filings on EDGAR ↗
Registration
Form S-1, first filed 2005-08-18; 0 initial registrations, 1 amendment
Outcome
Declared effective 2007-08-07
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
3530 TORINGDON WAY, SUITE 200, Charlotte, NC 28277
EIN
20-3174202
EDGAR entity type
operating
Insiders and CEO pay
Chelsea Therapeutics International, Ltd. on the corporate pages

Offering terms

Proposed price range
$7.50–$13.70 per share (S-1/A filed 2005-08-18)
Shares offered
6,122,211
Listing
under the symbol CHTP.OB

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 2

FiledFormWhat it isName as filedEDGAR
2005-08-18S-1/AS-1/A (amendment)Chelsea Therapeutics International, Ltd.0001193125-05-170790 ↗
2007-08-07EFFECTEFFECT (declared effective)Chelsea Therapeutics International, Ltd.9999999995-07-003146 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2005-08-18S-1/Aregistration statement$7.50–$13.706,122,211- CHTP.OB0primary document; range, price sentence, shares headline, proceeds computed, price outside the range droppeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Clemens KevanDirector132006–2014
Herskowitz NeilDirector32006–2008
Hewitt L ArthurOfficerChief Scientific Officer; Vice Pres. of Drug Development132006–2014
LAU JOHNSON YIU NAMDirector102006–2012
Riehle J NickOfficerChief Financial Officer142006–2014
Stein JasonDirector42006–2007
WEISER MICHAELDirector202006–2014
Pedder SimonDirector,OfficerChief Executive Officer122006–2012
Cohen Arthur BruceTenPercentOwner32006–2007
Healey Joseph PatrickTenPercentOwner32006–2007
HealthCor Management, L.P.TenPercentOwner32006–2007
Schmidt KeithOfficerChief Commercial Officer; Vice Pres. Marketing and Sales102007–2014
BRIVIO ROBERT J JRTenPercentOwner32007
Davidson Kemper Healthcare International LtdTenPercentOwner32007
DAVIDSON KEMPNER ADVISERS INCTenPercentOwner32007
Davidson Kempner Healthcare Fund L PTenPercentOwner32007
DAVIDSON KEMPNER INSTITUTIONAL PARTNERS LPTenPercentOwner32007
DAVIDSON KEMPNER INTERNATIONAL ADVISORS LLCTenPercentOwner32007
DAVIDSON KEMPNER INTERNATIONAL LTDTenPercentOwner32007
DAVIDSON KEMPNER PARTNERSTenPercentOwner32007
DAVIDSON MARVIN HTenPercentOwner32007
DAVIDSON SCOTT ETenPercentOwner32007person page Fuzzy
DK Group LLCTenPercentOwner32007
DK Management Partners LPTenPercentOwner32007
DOWICZ STEPHEN MTenPercentOwner32007
Epstein Eric PhilipTenPercentOwner32007
Friedman Avram ZTenPercentOwner32007
KEMPNER THOMAS L JRTenPercentOwner32007
LEFFELL MICHAEL JTenPercentOwner32007person page Fuzzy
LEVART TIMOTHY ITenPercentOwner32007person page Fuzzy
M H Davidson & CoTenPercentOwner32007
MHD MANAGEMENT COTenPercentOwner32007
Yoseloff Anthony AlexanderTenPercentOwner32007
AUSTIN JOSIAH TTenPercentOwner1012007–2012
El Coronado Holdings, LLCTenPercentOwner1012007–2012
HealthCor Associates, LLCTenPercentOwner22007
HealthCor Capital, L.P.TenPercentOwner22007
HealthCor Group, LLCTenPercentOwner22007
HEALTHCOR L PTenPercentOwner22007
HARDMAN NORMAN PHDDirector72008–2012
STOLL ROGER G PHDDirector172008–2014
Oliveto JosephDirector,Officer; OfficerInterim President and CEO; President and CEO; Vice President of Operations112008–2014
Schwieterman William DDirector; OfficerChief Medical Officer142008–2014
Rueckert William DodgeDirector132009–2014
Roberts Michael JOfficerVP, Business Development102010–2014
Hove Anders DTenPercentOwner42010–2011
ROBERTS BRYAN ETenPercentOwner42010–2011
VENROCK HEALTHCARE CAPITAL PARTNERS LPTenPercentOwner42010–2011
VHCP Co-Investment Holdings, LLCTenPercentOwner42010–2011
VHCP Management, LLCTenPercentOwner42010–2011

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerChelsea Therapeutics International, Ltd.SEC filers (EDGAR)CIK (EXACT)
Person pageMichael J LeffellPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)
Person pageScott E DavidsonPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)
Person pageTimothy I LevartPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), NC first:

More with this interest.

In other datasets, the same topic (Health) in NC:

Interests: Biological Products, (No Diagnostic Substances) · Health